AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 DEC 17 - (NewsRx.com & NewsRx.net) -- Priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8[superscript]+-T-cell epitope from the circumsporozoite protein of Plasmodium yoelii was protective against malaria.
"We immunized mice with an attenuated (cold-adapted) influenza virus followed by an attenuated vaccinia virus (modified vaccinia virus Ankara), both expressing a CD8[superscript]+-T-cell epitope derived from malaria sporozoites," researchers in the United States and Spain report.
"This vaccination regimen elicited high levels of protection against malaria," said Gloria Gonzalez-Aseguinolaza and collaborators at New York University in the U.S. and the Centro Nacional de Biotecnologia in Spain. "This is the first time that the vaccine efficacy of a recombinant cold-adapted influenza virus vector expressing a foreign antigen has been evaluated."
Gonzalez-Aseguinolaza and her coauthors published their study in the ...
Source: HighBeam Research, Expression of protein of Plasmodium yoelii protects against malaria.